Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug

被引:0
|
作者
Sethuraman V.V. [1 ]
Hickey A.J. [2 ]
机构
[1] Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill
[2] School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill
关键词
Aerosol dispersion; Cohesive energy density; Dry powder inhalers; Surface area; Surface energy;
D O I
10.1208/pt030428
中图分类号
学科分类号
摘要
The purpose of this study was to determine if aerosol delivery of drug loaded microparticles to lungs infected with Mycobacterium tuberculosis may be achieved by predicting dispersion of dry powders through knowledge of particle surface properties. Particle sizes of rifampicin-loaded poly (lactide-co-glycolide) microparticles (R-PLGA), rifampicin alone, and lactose and maltodextrin carrier particles (bulk and 75-125-μ sieved fractions) were determined by electron microscopy for the projected area diameter (Dp) and laser diffraction for the volume diameter (Dv). Surface energies (y) of R-PLGA, rifampicin alone, lactose, and maltodextrin were obtained by inverse phase gas chromatography, surface areas (Sa) by N2 adsorption, and cohesive energy densities by calculation. Particle dispersion was evaluated (Andersen nonviable impactor) for 10% blends of R-PLGA and rifampicin alone with bulk and sieved fractions of the carriers. Dp for R-PLGA and rifampicin alone was 3.02 and 2.83 μm, respectively. Dv was 13 ± 1 and 2 ± 1 μm for R-PLGA and rifampicin alone, respectively, indicating that R-PLGA was more aggregated. This was evident in y of 35 ± 1 and 19 ± 6 mJ/m 2 for RPLGA and rifampicin alone. Dp for lactose and maltodextrin (sieved and bulk) was approximately 40 mm. Bulk maltodextrin (Dv = 119 ± 6 mm) was more aggregated than bulk lactose (Dv = 54 ± 2 mm). This was a result of the higher Sa for maltodextrin (0.54 m2/g) than for lactose (0.21 m2/g). The y of bulk lactose and maltodextrin was 40 ± 4 and 60 ± 6 mJ/m 2 and of sieved lactose and maltodextrin was 39 ± 1 and 50 ± 1 mJ/m2. Impaction studies yielded higher fine particle fractions of R-PLGA from sieved lactose, 13% ± 3%, than from sieved maltodextrin, 7% ± 1%, at 90 L/min. An expression, based on these data, is proposed as a predictor of drug dispersion from carrier particles. Delivery of dry powder formulations can be achieved by characterizing particle surfaces and predicting impact on dispersion.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] DRY POWDER INHALER FOR LUNG TO HEART DRUG DELIVERY
    Huet, Gildas
    Audibert, Raphaele
    Raphael, Vincey
    Giraud, Myriam
    Quarta, Eride
    Colombo, Paolo
    Buttini, Francesca
    Penel, Thade
    Hammou, Asma Ait Sidi
    Ben Saidane, Lilia Petit
    Vecellio, Laurent
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (03) : A12 - A12
  • [2] Drug delivery performance of the mometasone furoate dry powder inhaler
    Yang, TT
    Li, S
    Wyka, B
    Kenyon, D
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (04): : 487 - 494
  • [3] The clinical relevance of dry powder inhaler performance for drug delivery
    Demoly, Pascal
    Hagedoorn, Paul
    de Boer, Anne H.
    Frijlink, Henderik W.
    RESPIRATORY MEDICINE, 2014, 108 (08) : 1195 - 1203
  • [4] Development of dry powder inhaler formulations for drug delivery systems
    Akdag, Yagmur
    JOURNAL OF RESEARCH IN PHARMACY, 2019, 23 (06): : 973 - 987
  • [5] Scintigraphic assessment of drug delivery from the ultrahaler dry powder inhaler
    Pitcairn, GR
    Lim, J
    Hollingworth, A
    Newman, SP
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1997, 10 (04): : 295 - 306
  • [6] Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler
    Coates, Matthew S.
    Chan, Hak-Kim
    Fletcher, David F.
    Chiou, Herbert
    PHARMACEUTICAL RESEARCH, 2007, 24 (08) : 1450 - 1456
  • [7] Influence of Mouthpiece Geometry on the Aerosol Delivery Performance of a Dry Powder Inhaler
    Matthew S. Coates
    Hak-Kim Chan
    David F. Fletcher
    Herbert Chiou
    Pharmaceutical Research, 2007, 24 : 1450 - 1456
  • [8] Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate
    Mehta, Rashmi
    Moore, Alison
    Riddell, Kylie
    Joshi, Shashidhar
    Chan, Robert
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (05) : 332 - 338
  • [9] The Impact of Common Inhaler Errors on Drug Delivery: Investigating Critical Errors with a Dry Powder Inhaler
    Sulaiman, Imran
    Seheult, Jansen
    Sadasivuni, Nirmal
    MacHale, Elaine
    Killane, Isabelle
    Giannoutsos, Spiros
    Cushen, Breda
    Mokoka, Matshediso Constantina
    Bhreathnach, Aoife Sartini
    Boland, Fiona
    Reilly, Richard B.
    Costello, Richard W.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (04) : 247 - 255
  • [10] The influence of drug morphology on the aerosolisation efficiency of dry powder inhaler formulations
    Adi, Handoko
    Traini, Daniela
    Chan, Hak-Kim
    Young, Paul M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (07) : 2780 - 2788